Equillium to Participate in Stifel’s 2026 Virtual Immunology and Inflammation Forum
Equillium (EQ) will participate in a fireside chat at Stifel’s 2026 Virtual Immunology and Inflammation Forum on Wednesday, September 23, 2026 at 12:00 p.m. EDT.
Rhea-AI Summary
Equillium (EQ) will participate in a fireside chat at Stifel’s 2026 Virtual Immunology and Inflammation Forum on Wednesday, September 23, 2026 at 12:00 p.m. EDT.
Equillium management will also be available for meetings with registered conference investors. A live webcast of the fireside chat will be accessible via the Events & Presentations page in the Investor Relations section of equilliumbio.com, with a replay available for approximately 45 days after the conference.
Positive
- None.
Negative
- None.
Details
Market Reaction – EQ
Following this news, EQ has declined 3.17%, reflecting a moderate negative market reaction. The stock is currently trading at $1.99. Trading volume is very high at 3.6x the average, suggesting heavy selling pressure.
Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.
Key Figures
- Fireside chat
- September 23, 2026 at 12:00pm EDT
- Stifel’s 2026 Virtual Immunology and Inflammation Forum
AI-generated analysis. How Rhea-AI works. Not financial advice.
LA JOLLA, Calif., Sept. 16, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders, today announced that management will be participating in a fireside chat at Stifel’s 2026 Virtual Immunology and Inflammation Forum on Wednesday, September 23, 2026 at 12:00pm EDT.
Members of the Equillium management team will be available to meet with investors who are registered to attend the conference.
A live webcast of the fireside chat may also be accessed on the Events & Presentations page, located under the Investor Relations section on equilliumbio.com. A replay of the webcast will be available for approximately 45 days following the conference.
About Equillium
Equillium is a biotechnology innovator with a mission to develop highly impactful therapies to treat severe autoimmune and inflammatory disorders.
For more information, visit www.equilliumbio.com.
Investor Contact
PJ Kelleher
LifeSci Advisors, LLC
+1-617-430-7579
pkelleher@lifesciadvisors.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
When and where is Equillium’s fireside chat at Stifel’s 2026 Virtual Immunology and Inflammation Forum?
The fireside chat is scheduled for Wednesday, September 23, 2026 at 12:00 p.m. EDT as part of Stifel’s 2026 Virtual Immunology and Inflammation Forum.
How can investors access the live webcast of Equillium’s fireside chat?
The live webcast may be accessed on the Events & Presentations page under the Investor Relations section of equilliumbio.com.
Will a replay of the Equillium fireside chat be available after the event?
Yes. A replay of the webcast will be available on Equillium’s website for approximately 45 days following the conference.
Can investors meet with Equillium management during Stifel’s 2026 Forum?
Members of the Equillium management team will be available to meet with investors who are registered to attend the conference.